Compare APEI & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APEI | WVE |
|---|---|---|
| Founded | 1991 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 875.2M | 744.8M |
| IPO Year | 2007 | 2015 |
| Metric | APEI | WVE |
|---|---|---|
| Price | $43.28 | $3.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 18 |
| Target Price | ★ $62.83 | $18.53 |
| AVG Volume (30 Days) | 194.0K | ★ 2.8M |
| Earning Date | 11-09-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 147.27 | N/A |
| EPS | ★ 1.46 | N/A |
| Revenue | ★ $198,174,000.00 | $3,704,000.00 |
| Revenue This Year | $6.88 | $20.53 |
| Revenue Next Year | $5.93 | N/A |
| P/E Ratio | $28.15 | ★ N/A |
| Revenue Growth | N/A | ★ 149.43 |
| 52 Week Low | $30.20 | $3.56 |
| 52 Week High | $61.59 | $21.73 |
| Indicator | APEI | WVE |
|---|---|---|
| Relative Strength Index (RSI) | 44.55 | 36.57 |
| Support Level | $42.72 | N/A |
| Resistance Level | $45.25 | $6.33 |
| Average True Range (ATR) | 1.74 | 0.21 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 46.62 | 38.99 |
American Public Education Inc provides online and campus based postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator, provides online postsecondary education as a distance-learning, graduate-level institution for military officers seeking a degree in military studies; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.